312 related articles for article (PubMed ID: 26567630)
21. Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling.
Dudgeon C; Casabianca A; Harris C; Ogier C; Bellina M; Fiore S; Bernet A; Ducarouge B; Goldschneider D; Su X; Pitarresi J; Hezel A; De S; Narrow W; Soliman F; Shields C; Vendramini-Costa DB; Prela O; Wang L; Astsaturov I; Mehlen P; Carpizo DR
Cell Rep; 2023 Nov; 42(11):113369. PubMed ID: 37922311
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between KRAS, SRC and YAP Signaling in Pancreatic Cancer: Interactions Leading to Aggressive Disease and Drug Resistance.
Rozengurt E; Eibl G
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680275
[TBL] [Abstract][Full Text] [Related]
23. Novel therapeutics to treat chronic pancreatitis: targeting pancreatic stellate cells and macrophages.
Iyer S; Enman M; Sahay P; Dudeja V
Expert Rev Gastroenterol Hepatol; 2024; 18(4-5):171-183. PubMed ID: 38761167
[TBL] [Abstract][Full Text] [Related]
24. The 2022 George E Palade Medal Lecture: Toxic Ca
Petersen OH
Pancreatology; 2023 Jan; 23(1):1-8. PubMed ID: 36539315
[TBL] [Abstract][Full Text] [Related]
25. Experimental Acute Pancreatitis Models: History, Current Status, and Role in Translational Research.
Yang X; Yao L; Fu X; Mukherjee R; Xia Q; Jakubowska MA; Ferdek PE; Huang W
Front Physiol; 2020; 11():614591. PubMed ID: 33424638
[TBL] [Abstract][Full Text] [Related]
26. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
27. YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells.
Yuan Y; Li D; Li H; Wang L; Tian G; Dong Y
Mol Med Rep; 2016 Jan; 13(1):237-42. PubMed ID: 26572166
[TBL] [Abstract][Full Text] [Related]
28. Key role of pancreatic stellate cells in pancreatic cancer.
Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV
Cancer Lett; 2016 Oct; 381(1):194-200. PubMed ID: 26571462
[TBL] [Abstract][Full Text] [Related]
29. The interplay between centrosomes and the Hippo tumor suppressor pathway.
Bolgioni AF; Ganem NJ
Chromosome Res; 2016 Jan; 24(1):93-104. PubMed ID: 26582635
[TBL] [Abstract][Full Text] [Related]
30. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.
Murakami S; Shahbazian D; Surana R; Zhang W; Chen H; Graham GT; White SM; Weiner LM; Yi C
Oncogene; 2017 Mar; 36(9):1232-1244. PubMed ID: 27546622
[TBL] [Abstract][Full Text] [Related]
31. Fat4 suppression induces Yap translocation accounting for the promoted proliferation and migration of gastric cancer cells.
Ma L; Cui J; Xi H; Bian S; Wei B; Chen L
Cancer Biol Ther; 2016; 17(1):36-47. PubMed ID: 26575609
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector.
Xu J; Li PX; Wu J; Gao YJ; Yin MX; Lin Y; Yang M; Chen DP; Sun HP; Liu ZB; Gu XC; Huang HL; Fu LL; Hu HM; He LL; Wu WQ; Fei ZL; Ji HB; Zhang L; Mei CL
Clin Sci (Lond); 2016 Mar; 130(5):349-63. PubMed ID: 26574480
[TBL] [Abstract][Full Text] [Related]
33. K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.
Wang MT; Holderfield M; Galeas J; Delrosario R; To MD; Balmain A; McCormick F
Cell; 2015 Nov; 163(5):1237-1251. PubMed ID: 26590425
[TBL] [Abstract][Full Text] [Related]
34. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
[TBL] [Abstract][Full Text] [Related]
35. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.
Kim M; Kim M; Park SJ; Lee C; Lim DS
EMBO Rep; 2016 Jan; 17(1):64-78. PubMed ID: 26598551
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Central Pocket in Human Transcription Factor TEAD as a Potential Cancer Therapeutic Strategy.
Pobbati AV; Han X; Hung AW; Weiguang S; Huda N; Chen GY; Kang C; Chia CS; Luo X; Hong W; Poulsen A
Structure; 2015 Nov; 23(11):2076-86. PubMed ID: 26592798
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
38. A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer.
von Eyss B; Jaenicke LA; Kortlever RM; Royla N; Wiese KE; Letschert S; McDuffus LA; Sauer M; Rosenwald A; Evan GI; Kempa S; Eilers M
Cancer Cell; 2015 Dec; 28(6):743-757. PubMed ID: 26678338
[TBL] [Abstract][Full Text] [Related]
39. Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation.
Kim MH; Kim J; Hong H; Lee SH; Lee JK; Jung E; Kim J
EMBO J; 2016 Mar; 35(5):462-78. PubMed ID: 26668268
[TBL] [Abstract][Full Text] [Related]
40. A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions.
Bertero T; Cottrill KA; Annis S; Bhat B; Gochuico BR; Osorio JC; Rosas I; Haley KJ; Corey KE; Chung RT; Nelson Chau B; Chan SY
Sci Rep; 2015 Dec; 5():18277. PubMed ID: 26667495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
